Pharma Stability: Insights, Guidelines, and Expertise
SOP for Conducting Stability Studies for Modified Release Products per FDA and ICH Guidelines Guidelines for Stability Testing of Modified Release Products 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide a procedure for conducting stability studies of modified release drug products in accordance with US FDA and ICH guidelines. This…
SOP for Designing Stability Studies for Combination Products as per Regulatory Guidelines Guidelines for Stability Studies of Combination Products 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for designing stability studies for combination products in accordance with relevant regulatory guidelines. This SOP ensures that stability studies provide adequate…
SOP for Implementing ICH Q1E for Stability Data Evaluation Guidelines for Stability Data Evaluation as per ICH Q1E 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for evaluating stability data of drug substances and products in accordance with the ICH Q1E guidelines. This SOP ensures consistent and scientifically…
Read More “SOP for Implementing ICH Q1E for Stability Data Evaluation” »
SOP for Conducting Stability Studies for Drug Substances Under US FDA Guidelines Guidelines for Stability Testing of Drug Substances as per US FDA 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedure for conducting stability studies for drug substances in accordance with US FDA guidelines. This SOP ensures that…
Read More “SOP for Conducting Stability Studies for Drug Substances Under US FDA Guidelines” »
SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1) Guidelines for Creating Stability-Indicating Methods as per ICH Q2(R1) 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for developing and validating a stability-indicating method for drug substances and drug products in accordance with the ICH Q2(R1) guidelines….
Read More “SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1)” »
SOP for Addressing Stability Issues in ANDA Submissions to the US FDA Guidelines for Managing Stability Issues in ANDA Submissions 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidance on identifying, investigating, and resolving stability issues in Abbreviated New Drug Application (ANDA) submissions to the United States Food and Drug…
Read More “SOP for Addressing Stability Issues in ANDA Submissions to the US FDA” »
SOP for Conducting Stability Studies for Biologics Following FDA Guidelines Guidelines for Stability Testing of Biologics as per FDA Guidelines 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for conducting stability studies for biological drug substances and products in accordance with the US FDA guidelines. This SOP aims…
Read More “SOP for Conducting Stability Studies for Biologics Following FDA Guidelines” »
SOP for Implementing Stability Studies for Drug Products in Compliance with US FDA CFR Title 21 Guidelines for Stability Studies as per US FDA CFR Title 21 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for conducting stability studies of drug products in compliance with the US FDA…
SOP for Preparing a Stability Protocol in Accordance with ICH Q1A(R2) Guidelines for Developing a Stability Protocol as per ICH Q1A(R2) 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for preparing a stability protocol for drug substances and drug products in compliance with the ICH Q1A(R2) guidelines. This…
Read More “SOP for Preparing a Stability Protocol in Accordance with ICH Q1A(R2)” »
SOP for Conducting Stability Studies in Compliance with Japanese Regulatory Requirements (PMDA) Standard Operating Procedure for Stability Testing According to PMDA Guidelines 1) Purpose The purpose of this SOP is to provide a standardized procedure for conducting stability studies in compliance with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) guidelines to ensure the safety,…